TREACE MEDICAL CONCEPTS INC (TMCI)
US89455T1097 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -61.52M | -49.53M | -42.82M | -20.55M | -3.67M | |||
| Depreciation Amortization | 7.95M | 5.35M | 2.13M | 690.00K | 1.21M | |||
| Change In Working Capital | -9.93M | -9.74M | -5.81M | -1.33M | -5.32M | |||
| Interest Paid | 5.04M | 5.17M | 4.40M | 3.90M | 1.15M | |||
| Other non cash items | 31.08M | 19.34M | 15.84M | 4.00M | 3.28M | |||
| OPERATING CASH FLOW | -32.42M | -34.58M | -30.65M | -17.19M | -4.49M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -10.77M | -11.46M | -14.84M | -2.71M | -1.07M | |||
| Other Investing Activity | 47.73M | -69.84M | -61.68M | N/A | N/A | |||
| INVESTING CASH FLOW | 36.97M | -81.30M | -76.52M | -2.71M | -1.07M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 19.61M | -1.79M | 11.32M | |||
| Stock Issued/Repurchased | 547.00K | 109.40M | 2.19M | 109.44M | 360.00K | |||
| Other Financing Activity | -250.00K | -13.00K | -990.00K | 0.00 | -180.00K | |||
| FINANCING CASH FLOW | 297.00K | 109.38M | 20.81M | 107.65M | 11.50M | |||
| CHANGE IN CASH | 4.84M | -6.49M | -86.36M | 87.75M | 5.94M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -32.42M | -34.58M | -30.65M | -17.19M | -4.49M | |||
| Capital Expenditure | -10.77M | -11.46M | -14.84M | -2.71M | -1.07M | |||
| FREE CASH FLOW | -43.19M | -46.03M | -45.49M | -19.90M | -5.56M | |||
All data in USD